Abbott announces CE mark approval for its COVID-19 laboratory based antibody test in India
Abbott announced that it received CE Mark to the IVD Directive (98/79/EC) for its laboratory-based serology blood test for the detection of the antibody, IgG, that identifies if a person has had the novel coronavirus (COVID-19)
CE Mark Approval For Its COVID-19 Laboratory Base | 05/05/2020 | By Darshana | 340
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy